On June 11, 2014, the Board of Directors of Ocera Therapeutics, Inc. (Nasdaq: OCRX) appointed Sharon Tetlow as Acting Chief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE